Centre orders 11 mn doses of Oxford-AstraZeneca vaccine from SII at Rs 210 each

Doses of the vaccine, Covishield, will initially be shipped to 60 consignee points and will then be distributed to various vaccination centres across India

Press Trust of India January 11, 2021 23:35:30 IST
Centre orders 11 mn doses of Oxford-AstraZeneca vaccine from SII at Rs 210 each

Representational image. PTI

New Delhi: The Union government on Monday placed a purchase order with Serum Institute of India (SII) for 11 million doses of Oxford COVID-19 vaccine, Covishield, each costing Rs 210 including GST, official sources said.

Dispatch of the vaccine is likely to start by late Monday evening, they said. According to the order placed, each dose of the vaccine has been priced at Rs 200 and with GST of Rs 10 it would cost Rs 210.

The health ministry is also likely to soon sign a purchase order for another anti- Coronavirus vaccine, Covaxin, which has been indigenously developed by Bharat Biotech, a source said.

Covishield vaccine doses would be initially shipped to 60 consignee points from where those would be distributed to various vaccination centres across India, the sources said.

As many as 2,54,500 doses of Covishield are set to be delivered at Delhi's central storage, Rajiv Gandhi Super Speciality hospital, in Tahirpur.

The HLL Lifecare Limited, a public sector undertaking, issued the supply order on behalf of the Union Health Ministry in the name of Prakash Kumar Singh, Additional Director, Government and Regulatory Affairs at Serum Institute of India.

"The Ministry of Health has nominated HLL Lifecare Limited vide letter dated January 11 as procuring agency for procurement of vaccine. For the purpose of this order, the Ministry of Health, Government of India is the 'purchaser' and HLL Lifecare Limited (HLL) is 'procuring agency'.

Vaccine-laden trucks will move out from Manjari location of the Pune-based SII amid elaborate police security. The Maharashtra government has decided to provide police security to the trucks carrying the vaccine up to airports and to the borders of the state.

India had recently approved two vaccines, Oxford's Covishield manufactured by the Serum Institute in the country and Bharat Biotech's Covaxin, for restricted emergency use.

According to the Health Ministry, two doses of the vaccine need to be taken by an individual 28 days apart to complete the immunisation schedule. Protective levels of antibodies are generally developed two weeks after receiving the second dose, it has said.

The country will launch its COVID-19 vaccination drive from January 16 in what Prime Minister Narendra Modi has called the world's largest inoculation programme with priority to be given to nearly three crore healthcare and frontline workers.

According to the ' COVID-19 Vaccine Operational Guidelines", the shots will be offered first to healthcare workers, and frontline workers and then to persons above 50 years of age, followed by persons younger than 50 years of age with associated comorbidities based on evolving pandemic situation.

Updated Date:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Coronavirus News Updates: Centre should bear cost of COVID-19 vaccine for the poor, says Rajesh Tope
Health

Coronavirus News Updates: Centre should bear cost of COVID-19 vaccine for the poor, says Rajesh Tope

Coronavirus News Updates: The Maharashtra health minister said two doses (of a COVID-19 vaccine) will cost Rs 500 and the state government will take "appropriate" steps if the Centre doesn't take steps regarding its expectation

Coronavirus News Updates: COVID-19 expert panel recommends emergency use authorisation for Bharat Biotech's COVAXIN
Health

Coronavirus News Updates: COVID-19 expert panel recommends emergency use authorisation for Bharat Biotech's COVAXIN

Coronavirus News LIVE Updates: Covaxin has been indigenously developed by Bharat Biotech in collaboration with the ICMR

All Covid-19 vaccines from India being developed for storage at 2-8 deg Celsius: DBT Secy
India

All Covid-19 vaccines from India being developed for storage at 2-8 deg Celsius: DBT Secy

Logistics at many stages have been worked out keeping this target temperature in mind to meet storage availability.